Загрузка...
Diabetes and gout: efficacy and safety of febuxostat and allopurinol
Aim Assess influences of demographics and co-morbidities of gout patients with or without diabetes on safety and efficacy of urate-lowering agents. Methods Post-hoc analysis of 312 diabetic and 1957 non-diabetic gout patients [baseline serum urate levels (sUA) ≥8.0 mg/dl] enrolled in a 6-month rando...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Blackwell Publishing Ltd
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3902994/ https://ncbi.nlm.nih.gov/pubmed/23683134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12135 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|